MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for Multiple Myeloma
95 locations incl. Mobile
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06152575·Phase 3·Recruiting·Listed Nov 2023